Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Key Information Document Announcement

4 Jan 2018 09:01

RNS Number : 9065A
LMS Capital PLC
04 January 2018
 

4 January 2018

 

LMS Capital Plc ("LMS Capital Plc" or the "Company")

 

Key Information Document Announcement

 

Further to our obligations under the Packaged Retail and Insurance-based Investment Products ("PRIIPs") Regulation we are required by law to publish a three-page Key Information Document ("KID") to help potential investors understand the nature, risk and costs of this product and to allow comparison with others. The content of the document is highly prescriptive, both in terms of the calculations underlying the numbers and the narrative, with limited ability to add further context and explanations, and therefore we believe the KID should be used in conjunction with other material produced by the Company including the annual and interim reports, factsheets and presentations, all of which are available on the Company's website. 

 

ENDS

For further information, please contact:

 

LMS Capital plc Martin Knight 020 3837 6270

Chairman

 

Gresham House Asset Management Ltd Graham Bird 020 3837 6270

Investment Manager

J.P. Morgan Cazenove Michael Wentworth-Stanley 020 7742 4000

(Nominated Adviser and Broker)

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKNDQOBKDQDK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.